Search tips
Search criteria 


Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. 1996 January; 64(1): 28–36.
PMCID: PMC173723

Immunologic characteristics of a Streptococcus mutans glucosyltransferase B sucrose-binding site peptide-cholera toxin B-subunit chimeric protein.


Glucosyltranferases (Gtfs) produced by the mutans streptococci are recognized as virulence factors in dental caries, and the inhibition of Gtfs by secretory immunoglobulin A is predicted to provide protection against this disease. The basis of such mucosal immunity is linked to the ability to reliably stimulate production of secretory immunoglobulin A against Gtfs. In this regard, we are exploring the immunogenicities of various Gtf peptides genetically fused to the B subunit of cholera toxin (CTB), a known mucosal adjuvant. In this work, we have created a gene fusion linking the GtfB active-site (AS) peptide DANFDSIRVDAVDNVDADLLQIA to the amino terminus of CTB. This sequence, deduced from the nucleotide sequence of gtfB from Streptococcus mutans GS5, has been found to be strongly conserved in Gtfs from several mutans streptococci. We have purified this recombinant protein (AS:CTB) from Escherichia coli carrying the fusion gene under the control of the lactose operon promoter. This protein was immunogenic in rabbits and produced specific serum antibodies against both the Gtf peptide and the CTB moiety. The antiserum was tested for its ability to inhibit GtfB activity obtained from a mutant of S. mutans able to make only this enzyme and none of the other usual Gtfs or fructosyltransferase. Approximately 50% of the GtfB activity was inhibited in such assays. These results suggest that the AS of this enzyme is accessible to antibody binding and that this region of the protein may be considered a vulnerable target for vaccine design and development. The AS:CTB was able to bind GM1, ganglioside in enzyme-linked immunosorbent assays, indicating that the recombinant protein retained this property, which is though to be critical to the mucosal immunoadjuvant properties of CTB. Thus, this protein may be promising as a candidate anticaries vaccinogen alone or in combination with other Gtf peptides or conjugates.

Full Text

The Full Text of this article is available as a PDF (350K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abo H, Matsumura T, Kodama T, Ohta H, Fukui K, Kato K, Kagawa H. Peptide sequences for sucrose splitting and glucan binding within Streptococcus sobrinus glucosyltransferase (water-insoluble glucan synthetase). J Bacteriol. 1991 Feb;173(3):989–996. [PMC free article] [PubMed]
  • Aoki H, Shiroza T, Hayakawa M, Sato S, Kuramitsu HK. Cloning of a Streptococcus mutans glucosyltransferase gene coding for insoluble glucan synthesis. Infect Immun. 1986 Sep;53(3):587–594. [PMC free article] [PubMed]
  • Bessen D, Fischetti VA. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Infect Immun. 1988 Oct;56(10):2666–2672. [PMC free article] [PubMed]
  • Boyer HW, Roulland-Dussoix D. A complementation analysis of the restriction and modification of DNA in Escherichia coli. J Mol Biol. 1969 May 14;41(3):459–472. [PubMed]
  • Chia JS, Hsu TY, Teng LJ, Chen JY, Hahn LJ, Yang CS. Glucosyltransferase gene polymorphism among Streptococcus mutans strains. Infect Immun. 1991 May;59(5):1656–1660. [PMC free article] [PubMed]
  • Chia JS, Lin RH, Lin SW, Chen JY, Yang CS. Inhibition of glucosyltransferase activities of Streptococcus mutans by a monoclonal antibody to a subsequence peptide. Infect Immun. 1993 Nov;61(11):4689–4695. [PMC free article] [PubMed]
  • Chia JS, Lin SW, Hsu TY, Chen JY, Kwan HW, Yang CS. Analysis of a DNA polymorphic region in the gtfB and gtfC genes of Streptococcus mutans. Infect Immun. 1993 Apr;61(4):1563–1566. [PMC free article] [PubMed]
  • Dertzbaugh MT, Elson CO. Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition. Infect Immun. 1993 Feb;61(2):384–390. [PMC free article] [PubMed]
  • Dertzbaugh MT, Macrina FL. Plasmid vectors for constructing translational fusions to the B subunit of cholera toxin. Gene. 1989 Oct 30;82(2):335–342. [PubMed]
  • Dertzbaugh MT, Macrina FL. Inhibition of Streptococcus mutans glucosyltransferase activity by antiserum to a subsequence peptide. Infect Immun. 1990 Jun;58(6):1509–1513. [PMC free article] [PubMed]
  • Dertzbaugh MT, Peterson DL, Macrina FL. Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein. Infect Immun. 1990 Jan;58(1):70–79. [PMC free article] [PubMed]
  • Devulapalle KS, Mooser G. Subsite specificity of the active site of glucosyltransferases from Streptococcus sobrinus. J Biol Chem. 1994 Apr 22;269(16):11967–11971. [PubMed]
  • Ferretti JJ, Gilpin ML, Russell RR. Nucleotide sequence of a glucosyltransferase gene from Streptococcus sobrinus MFe28. J Bacteriol. 1987 Sep;169(9):4271–4278. [PMC free article] [PubMed]
  • Giffard PM, Allen DM, Milward CP, Simpson CL, Jacques NA. Sequence of the gtfK gene of Streptococcus salivarius ATCC 25975 and evolution of the gtf genes of oral streptococci. J Gen Microbiol. 1993 Jul;139(7):1511–1522. [PubMed]
  • Giffard PM, Simpson CL, Milward CP, Jacques NA. Molecular characterization of a cluster of at least two glucosyltransferase genes in Streptococcus salivarius ATCC 25975. J Gen Microbiol. 1991 Nov;137(11):2577–2593. [PubMed]
  • Gilmore KS, Russell RR, Ferretti JJ. Analysis of the Streptococcus downei gtfS gene, which specifies a glucosyltransferase that synthesizes soluble glucans. Infect Immun. 1990 Aug;58(8):2452–2458. [PMC free article] [PubMed]
  • Hamada S, Slade HD. Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev. 1980 Jun;44(2):331–384. [PMC free article] [PubMed]
  • Hanada N, Isobe Y, Aizawa Y, Katayama T, Sato S, Inoue M. Nucleotide sequence analysis of the gtfT gene from Streptococcus sobrinus OMZ176. Infect Immun. 1993 May;61(5):2096–2103. [PMC free article] [PubMed]
  • Honda O, Kato C, Kuramitsu HK. Nucleotide sequence of the Streptococcus mutans gtfD gene encoding the glucosyltransferase-S enzyme. J Gen Microbiol. 1990 Oct;136(10):2099–2105. [PubMed]
  • Jones KF, Fischetti VA. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci. J Exp Med. 1988 Mar 1;167(3):1114–1123. [PMC free article] [PubMed]
  • Kaper JB, Lockman H, Baldini MM, Levine MM. Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature. 1984 Apr 12;308(5960):655–658. [PubMed]
  • Kato C, Kuramitsu HK. Carboxyl-terminal deletion analysis of the Streptococcus mutans glucosyltransferase-I enzyme. FEMS Microbiol Lett. 1990 Nov;60(3):299–302. [PubMed]
  • Kato C, Nakano Y, Lis M, Kuramitsu HK. Molecular genetic analysis of the catalytic site of Streptococcus mutans glucosyltransferases. Biochem Biophys Res Commun. 1992 Dec 15;189(2):1184–1188. [PubMed]
  • Laemmli UK, Favre M. Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol. 1973 Nov 15;80(4):575–599. [PubMed]
  • Loesche WJ. Role of Streptococcus mutans in human dental decay. Microbiol Rev. 1986 Dec;50(4):353–380. [PMC free article] [PubMed]
  • Macrina FL, Tobian JA, Jones KR, Evans RP, Clewell DB. A cloning vector able to replicate in Escherichia coli and Streptococcus sanguis. Gene. 1982 Oct;19(3):345–353. [PubMed]
  • McKenzie SJ, Halsey JF. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J Immunol. 1984 Oct;133(4):1818–1824. [PubMed]
  • Michalek SM, Childers NK. Development and outlook for a caries vaccine. Crit Rev Oral Biol Med. 1990;1(1):37–54. [PubMed]
  • Michalek SM, Childers NK, Katz J, Dertzbaugh M, Zhang S, Russell MW, Macrina FL, Jackson S, Mestecky J. Liposomes and conjugate vaccines for antigen delivery and induction of mucosal immune responses. Adv Exp Med Biol. 1992;327:191–198. [PubMed]
  • Mooser G, Hefta SA, Paxton RJ, Shively JE, Lee TD. Isolation and sequence of an active-site peptide containing a catalytic aspartic acid from two Streptococcus sobrinus alpha-glucosyltransferases. J Biol Chem. 1991 May 15;266(14):8916–8922. [PubMed]
  • Munro C, Michalek SM, Macrina FL. Cariogenicity of Streptococcus mutans V403 glucosyltransferase and fructosyltransferase mutants constructed by allelic exchange. Infect Immun. 1991 Jul;59(7):2316–2323. [PMC free article] [PubMed]
  • Munro CL, Michalek SM, Macrina FL. Sucrose-derived exopolymers have site-dependent roles in Streptococcus mutans-promoted dental decay. FEMS Microbiol Lett. 1995 May 15;128(3):327–332. [PubMed]
  • Nakano YJ, Kuramitsu HK. Mechanism of Streptococcus mutans glucosyltransferases: hybrid-enzyme analysis. J Bacteriol. 1992 Sep;174(17):5639–5646. [PMC free article] [PubMed]
  • Shimamura A, Nakano YJ, Mukasa H, Kuramitsu HK. Identification of amino acid residues in Streptococcus mutans glucosyltransferases influencing the structure of the glucan product. J Bacteriol. 1994 Aug;176(16):4845–4850. [PMC free article] [PubMed]
  • Shiroza T, Ueda S, Kuramitsu HK. Sequence analysis of the gtfB gene from Streptococcus mutans. J Bacteriol. 1987 Sep;169(9):4263–4270. [PMC free article] [PubMed]
  • Simpson CL, Giffard PM, Jacques NA. Streptococcus salivarius ATCC 25975 possesses at least two genes coding for primer-independent glucosyltransferases. Infect Immun. 1995 Feb;63(2):609–621. [PMC free article] [PubMed]
  • Smith DJ, Taubman MA, Holmberg CF, Eastcott J, King WF, Ali-Salaam P. Antigenicity and immunogenicity of a synthetic peptide derived from a glucan-binding domain of mutans streptococcal glucosyltransferase. Infect Immun. 1993 Jul;61(7):2899–2905. [PMC free article] [PubMed]
  • Smith DJ, Taubman MA, King WF, Eida S, Powell JR, Eastcott J. Immunological characteristics of a synthetic peptide associated with a catalytic domain of mutans streptococcal glucosyltransferase. Infect Immun. 1994 Dec;62(12):5470–5476. [PMC free article] [PubMed]
  • Stover CK, Vodkin MH, Oaks EV. Use of conversion adaptors to clone antigen genes in lambda gt11. Anal Biochem. 1987 Jun;163(2):398–407. [PubMed]
  • Studier FW, Moffatt BA. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986 May 5;189(1):113–130. [PubMed]
  • Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 1990;185:60–89. [PubMed]
  • Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. [PubMed]
  • Ueda S, Shiroza T, Kuramitsu HK. Sequence analysis of the gtfC gene from Streptococcus mutans GS-5. Gene. 1988 Sep 15;69(1):101–109. [PubMed]
  • Wong C, Hefta SA, Paxton RJ, Shively JE, Mooser G. Size and subdomain architecture of the glucan-binding domain of sucrose:3-alpha-D-glucosyltransferase from Streptococcus sobrinus. Infect Immun. 1990 Jul;58(7):2165–2170. [PMC free article] [PubMed]
  • Yamashita Y, Bowen WH, Burne RA, Kuramitsu HK. Role of the Streptococcus mutans gtf genes in caries induction in the specific-pathogen-free rat model. Infect Immun. 1993 Sep;61(9):3811–3817. [PMC free article] [PubMed]
  • Yamashita Y, Bowen WH, Kuramitsu HK. Molecular analysis of a Streptococcus mutans strain exhibiting polymorphism in the tandem gtfB and gtfC genes. Infect Immun. 1992 Apr;60(4):1618–1624. [PMC free article] [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)